The goal of this site is to provide quality answers, solutions, information, and tips about medical bills allowing individuals to focus on their health and not their medical bills. They are not a referral service. They are an online blog designed in assisting consumers in locating information about their medical bills and professionals who assist in the claims process.

Visit YourMedicalBills.com

Latisse was first approved by the FDA in 2001 for lowering intraocular pressure for people with glaucoma. (It is interesting to note that Botox was also originally approved for treating an eye disorder.) One of the side effects noticed by glaucoma patients were longer and fuller eyelashes. So, Allergan conducted another clinical trial to study the product’s aesthetic affect on eyelashes.

Study results showed the eyelashes of patients that were treated with Latisse typically grew 25% longer, 106% thicker and 18% darker. A small amount of patients (3.6%) experienced eye itching and red eyes. These results were presented to and reviewed by the Food and Drug Administration, which approved the drug in late December, 2008.

Latisse is a solution that is applied once daily to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. You can expect to see longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain desired results, continued treatment with Latisse is required. Therefore, if you discontinue using Latisse, your eyelashes will gradually return to where they were before you started using the product.

This is a great option for those who desire longer, fuller, and darker eyelashes. Learn more by visiting www.latisse.com.